Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Novagen Ingenium Inc. | novz_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported) November 24, 2016
NOVAGEN INGENIUM INC |
(Exact name of registrant as specified in its charter) |
Nevada | 333-149617 | 98-0471927 | ||
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
1846 Innovation Park Drive, Oro Valley, Arizona | 85755 | |
(Address of principal executive offices) | (Zip Code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers |
On November 22, 2016, Dr. Jon N. Leonard resigned as a director of Novagen Ingenium Inc. (the “Registrant”). Mr. Leonard advised the Registrant that he was resigning for personal reasons and not because of any disagreement with the Registrant or its management.
Item 7.01 | Regulation FD Disclosure |
On November 22, 2016, the Registrant issued a press release in the form attached to this Current Report on Form 8-K as Exhibit 99.1 (the “Press Release”).
The information in Item 7.01 of this Current Report on Form 8-K, including the Press Release, shall not be deemed “filed” for any purpose and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, regardless of any general incorporation language in such filing.
Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
99.1 | Press release of Novagen Ingenium, Inc. |
2 |
Signatures
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NOVAGEN INGENIUM INC. | |||
Date: November 24, 2016 | By: | /s/ Micheal Nugent | |
Micheal Nugent | |||
President & CEO | |||
3 |